butorphanol has been researched along with Migraine Disorders in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (72.73) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Loder, E | 1 |
| Benfield, P; Gillis, JC; Goa, KL | 1 |
| Couch, JR; Diamond, S; Elkind, AH; Goldstein, J; Hoffert, MJ; Kohlerman, NJ; Saper, JR; Solomon, S | 1 |
| Baumel, B | 1 |
| Kumar, KL | 1 |
| Robbins, L | 2 |
| Heller, MB; Melanson, SW; Morse, JW; Pronchik, DJ | 1 |
| Fisher, H | 1 |
| Elenbaas, RM; Evens, RP; Gratton, M; Iacono, CU; Koellner, KJ; Pribble, JP; Racz, G | 1 |
4 review(s) available for butorphanol and Migraine Disorders
| Article | Year |
|---|---|
Post-marketing experience with an opioid nasal spray for migraine: lessons for the future.
Topics: Administration, Intranasal; Analgesics, Opioid; Butorphanol; Drug Approval; Forecasting; Humans; Migraine Disorders; Product Surveillance, Postmarketing; United States; United States Food and Drug Administration | 2006 |
Transnasal butorphanol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in acute pain management.
Topics: Administration, Intranasal; Analgesics, Opioid; Butorphanol; Dosage Forms; Dose-Response Relationship, Drug; Drug Evaluation; Humans; Migraine Disorders; Pain; Pain, Postoperative; Receptors, Opioid; Respiration | 1995 |
Migraine: a pharmacologic review with newer options and delivery modalities.
Topics: Administration, Intranasal; Adrenergic beta-Antagonists; Anti-Inflammatory Agents, Non-Steroidal; Butorphanol; Calcium Channel Blockers; Ergotamine; Humans; Migraine Disorders; Sumatriptan | 1994 |
Recent advances in the acute management of migraine and cluster headaches.
Topics: Analgesics; Butorphanol; Capsaicin; Cluster Headache; Dihydroergotamine; Humans; Ketorolac; Metoclopramide; Migraine Disorders; Sumatriptan; Tolmetin | 1994 |
3 trial(s) available for butorphanol and Migraine Disorders
| Article | Year |
|---|---|
Transnasal butorphanol in the treatment of acute migraine.
Topics: Acute Disease; Administration, Intranasal; Adult; Butorphanol; Female; Humans; Male; Middle Aged; Migraine Disorders | 1995 |
Transnasal butorphanol in the emergency department management of migraine headache.
Topics: Administration, Intranasal; Adult; Analgesics, Opioid; Butorphanol; Female; Humans; Male; Middle Aged; Migraine Disorders; Narcotic Antagonists; Pain Measurement; Patient Satisfaction; Prospective Studies; Treatment Outcome | 1997 |
Dose effectiveness and safety of butorphanol in acute migraine headache.
Topics: Acute Disease; Adolescent; Adult; Aged; Butorphanol; Double-Blind Method; Female; Humans; Injections, Intramuscular; Male; Middle Aged; Migraine Disorders; Pain Measurement | 1991 |
4 other study(ies) available for butorphanol and Migraine Disorders
| Article | Year |
|---|---|
Nurse addicted to stadol sues manufacturer. Case on point: Uhiren v. Bristol-Myers Squibb Company, Inc., 346 F.3d 824--AR (2003).
Topics: Analgesics, Opioid; Arkansas; Butorphanol; Drug Industry; Humans; Migraine Disorders; Nurse Practitioners; Professional Impairment; Substance-Related Disorders | 2003 |
Stadol Nasal Spray--treatment for migraine?
Topics: Administration, Intranasal; Butorphanol; Humans; Migraine Disorders | 1993 |
Migraine research methods.
Topics: Analgesics, Opioid; Butorphanol; Chlorpromazine; Dopamine Antagonists; Humans; Migraine Disorders; Research; Sumatriptan; Vasoconstrictor Agents | 1997 |
Stadol nasal spray for headache.
Topics: Administration, Intranasal; Analgesics, Opioid; Butorphanol; Headache; Humans; Migraine Disorders | 2002 |